Bivariate analysis DNA/cytokeratin 7 and flow cytometric measurement of MIB-1 in superficial transitional carcinoma of the bladder (TCC). Methodological aspects and prognostic implications.
Leonardi
E
E
Department of Pathology, S. Chiara Hospital, Trento, Italy.
Cristofori
A
A
Reich
A
A
Dalla Palma
P
P
D034961:Antigens, Nuclear; D015415:Biomarkers / Q000032:analysis; D002295:Carcinoma, Transitional Cell / Q000737:chemistry* / Q000175:diagnosis / Q000235:genetics / Q000473:pathology; D004273:DNA, Neoplasm / Q000032:analysis*; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D053552:Keratin-7; D007633:Keratins / Q000032:analysis*; D019394:Ki-67 Antigen; D009687:Nuclear Proteins / Q000032:analysis*; D011003:Ploidies; D016196:S Phase; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D001749:Urinary Bladder Neoplasms / Q000737:chemistry* / Q000175:diagnosis / Q000235:genetics / Q000473:pathology
D034961:Antigens, Nuclear; D015415:Biomarkers; D004273:DNA, Neoplasm; C507497:KRT7 protein, human; D053552:Keratin-7; D019394:Ki-67 Antigen; D009687:Nuclear Proteins; D016159:Tumor Suppressor Protein p53; D007633:Keratins